HRS-9057 Injection

HRS-9057 · Fujian Shengdi Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-9057 Injection, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention [Phase 2]